Immediate Oncoplastic Surgery During Breast-Conserving Treatment

Quick answer: Immediate oncoplastic breast-conserving surgery combines removal of a breast tumour with reshaping or reconstruction of the remaining breast during the same operation. Instead of allowing the lumpectomy cavity to collapse and correcting a dent later, the surgeon plans the cancer excision and the breast shape together. Small defects may be closed by carefully rearranging nearby breast tissue. Larger defects can be treated with a breast-reduction pattern or by transferring nearby tissue, such as a lateral intercostal artery perforator (LICAP) flap. Cancer clearance remains the first priority; the reconstructive method is chosen around the tumour location, breast size, expected specimen volume, skin quality and radiotherapy plan.

A lumpectomy can preserve most of the breast, but preserving breast tissue does not automatically preserve breast shape. Removing a relatively large volume, particularly from a small breast or from a sensitive location near the nipple, inner breast or lower pole, can leave a hollow, flatten the breast, pull the nipple or create a visible step in the contour. Radiotherapy may make that difference more apparent over time by causing firmness and contraction.

Oncoplastic surgery addresses the problem at the moment when the anatomy is most favourable: before scarring and radiotherapy have fixed the tissues. It is not cosmetic surgery added after cancer treatment. It is a coordinated cancer and reconstructive operation in which tumour removal, margin assessment, specimen orientation, breast reshaping and radiotherapy planning are considered together.

What is immediate oncoplastic breast-conserving surgery?

Breast-conserving treatment usually consists of removing the tumour with a rim of healthy tissue, followed by radiotherapy when indicated. The surgical operation may be called lumpectomy, wide local excision, segmental resection or partial mastectomy. In a standard lumpectomy, the cavity may be closed directly or allowed to settle as healing progresses. That can work well when the removed volume is small and the surrounding tissue naturally supports the breast.

Oncoplastic breast-conserving surgery adds planned reshaping or partial reconstruction immediately after the oncological resection. The word “oncoplastic” joins oncology with plastic and reconstructive principles. The procedure can range from a limited glandular rearrangement through the same incision to a formal reduction mammoplasty or a muscle-sparing perforator flap from the chest wall.

“Immediate” means that the reshaping is performed during the same anaesthetic as the tumour removal. A delayed-immediate approach is also used in selected centres: the tumour is removed first, the pathology is reviewed and reconstruction follows soon afterwards, before radiotherapy. The appropriate timing depends on margin strategy, local practice, tumour biology and the reconstructive method.

The two goals: cancer control and breast shape

The operation is designed around two linked but unequal priorities. The first is complete and accurately documented removal of the cancer. The second is preservation or restoration of a natural breast contour. Reconstructive planning must never reduce the required cancer margin, obscure specimen orientation or delay necessary adjuvant treatment.

Done well, oncoplastic planning may let the surgeon remove a wider segment without leaving an unacceptable deformity. The pathologist still needs a clearly oriented specimen, and the breast team must know the original tumour-bed location after the tissue has been moved. Surgical clips are commonly placed around the cavity to support radiotherapy planning and future interpretation.

The cosmetic goal is not a perfectly unoperated breast. Scars, swelling, radiotherapy and natural asymmetry remain. The realistic objective is a breast that retains a balanced footprint, smooth contour and acceptable nipple position while delivering safe cancer treatment.

When can immediate oncoplastic surgery help?

Oncoplastic techniques are particularly useful when the expected defect is large relative to the breast, the tumour lies in a location prone to visible distortion, or the breast is already large, heavy or drooping and would benefit from reshaping. They may also expand the possibility of breast conservation for selected patients who would otherwise face a poor cosmetic result after standard lumpectomy.

• A moderate or large tumour-to-breast volume ratio.

• Removal of more than one nearby area or an extensive segment.

• Tumours close to the nipple, lower pole, inner breast or visible cleavage area.

• A small or medium breast in which local tissue cannot close the defect safely.

• A large or ptotic breast suited to an oncoplastic reduction.

• A lateral defect that can be replaced with LICAP or related chest-wall tissue.

• A wish to avoid or reduce the severity of a delayed post-lumpectomy deformity.

Not every lumpectomy needs complex reconstruction. A small resection in a favourable outer-breast location may heal with an excellent contour after simple closure. More surgery is not automatically better. The chosen technique should be proportionate to the predicted defect and should not add donor-site risk without a meaningful benefit.

Volume displacement: reshaping tissue already in the breast

Volume-displacement techniques move the remaining breast tissue into the lumpectomy defect. They work best when there is enough breast volume and tissue mobility to redistribute. The surgeon may release glandular tissue from the skin or chest wall, rotate it into the cavity and close it in layers. The nipple and surrounding breast are reshaped around the new internal arrangement.

Local glandular rearrangement

For a limited defect, nearby breast tissue can be advanced or rotated into the space. Incisions may sit around the areola, in the breast fold or along a natural contour. This avoids a separate donor site, but the tissue must move without excessive tension or damage to its blood supply. Closing only the superficial edges of a deep cavity can produce an internal void and later indentation, so three-dimensional planning matters.

Batwing and round-block techniques

A batwing pattern uses paired curved incisions above the areola and is useful for selected tumours in the upper central breast. It removes the tumour-bearing segment while allowing adjacent tissue to be advanced and the nipple position to remain balanced. A round-block or periareolar approach can provide access and redistribute tissue through a scar around the areola, although it is not suitable for every defect or breast shape.

Oncoplastic reduction mammoplasty

In a medium or large breast, the tumour can be incorporated into a reduction pattern. The surgeon removes the cancer and planned reduction tissue, protects the nipple on a vascular pedicle, reshapes the remaining breast and removes excess skin. The opposite breast may be reduced or lifted for symmetry, either during the same operation or later.

Vertical and anchor-shaped patterns are common, but the tumour location and nipple blood supply determine which pedicle and skin design are safe. The cancer side is not treated like a routine cosmetic reduction: specimen orientation, margin access and tumour-bed marking are essential parts of the operation.

Volume replacement: bringing nearby tissue into the defect

When the remaining breast is too small to rearrange without becoming distorted, tissue can be transferred from next to the breast. This is called volume replacement. Chest-wall perforator flaps use skin and fat supplied by small blood vessels that pass through or between the underlying muscles. The tissue is rotated or advanced into the lumpectomy cavity while the main muscles are preserved.

Volume replacement is especially valuable in a small or medium breast with little droop, where a reduction would remove too much of the remaining breast. The trade-off is an additional donor scar, a longer operation and flap-specific complications. The choice of flap depends largely on the position of the defect and the available tissue around the chest.

LICAP flap: replacing a lateral breast defect

LICAP stands for lateral intercostal artery perforator. A LICAP flap uses skin and fat from the side of the chest, usually near the bra line, while preserving the latissimus dorsi and other major muscles. Small perforating vessels arising from the intercostal circulation maintain the flap's blood supply. The tissue remains attached to its perforator and is rotated or advanced into the breast defect.

The LICAP flap is particularly suited to defects in the outer and lower-outer breast. It can replace volume immediately after a wide local excision in patients who do not have enough breast tissue for displacement. The donor scar can often be placed along the side or within the bra line, although scar position depends on the required flap design and body shape.

How the LICAP procedure is planned

Before surgery, the team identifies the tumour and estimates the expected resection. The patient is marked while standing because the breast and side-chest tissues shift when lying down. Available skin and fat are assessed, and handheld Doppler ultrasound or other imaging may be used to locate perforating vessels according to the surgeon's practice.

The reconstructive plan must remain flexible. The final cavity becomes clear only after the tumour and required margins are removed. A LICAP flap that is too small will not restore the contour, while excessive tissue can create bulk or tension. The design therefore considers both the predicted defect and possible extension if more tissue is required.

The LICAP operation step by step

1. Oncological resection. The breast surgeon removes the tumour with the planned margin and orients the specimen for pathology.

2. Assessment of the defect. The team examines the cavity, skin, nipple position and remaining breast volume.

3. Flap elevation. Skin and fat are raised from the lateral chest while protecting the selected perforator and underlying muscle.

4. Transfer into the breast. The flap is rotated or advanced into the cavity without twisting or compressing its blood supply.

5. Shaping and fixation. The tissue is secured in three dimensions to restore the outer breast curve and avoid a step at the flap edge.

6. Tumour-bed marking and closure. Clips are placed as indicated for radiotherapy, and the breast and donor site are closed, sometimes with a drain.

The skin paddle may be buried beneath the breast skin when only volume is needed, or part may remain visible if skin has also been removed. The exact design varies; a consultation should explain where the scar and any visible flap skin will sit.

Other chest-wall and regional flaps

LICAP is one member of a wider group. A lateral thoracic artery perforator (LTAP) flap can also replace lateral or upper-outer tissue. An anterior intercostal artery perforator (AICAP) flap brings tissue from the upper abdomen or lower chest into selected lower or inner defects. A thoracodorsal artery perforator (TDAP) flap uses back tissue based on perforators from the thoracodorsal system while aiming to spare the latissimus muscle.

These names describe the blood supply, not a one-size-fits-all operation. Tumour location, perforator anatomy, donor volume, previous scars and the surgeon's experience determine the safest option. In some lateral defects, combined LICAP and LTAP tissue may be used. More distant or complex flaps are not justified when a simple glandular rearrangement will give a reliable result.

How the technique is chosen

A useful planning framework compares the expected resection with the breast that will remain. Large breasts with droop often tolerate displacement and reduction. Smaller, relatively firm breasts may need volume replacement. A lateral defect points toward LICAP or LTAP; a lower or inner defect may be better served by an AICAP or a displacement pattern. Central tumours require careful planning around the nipple-areola complex.

The decision also considers whether skin must be removed, the predicted radiotherapy field, smoking, diabetes, body mass index, previous operations and the patient's priorities about scars and surgery on the other breast. The same tumour can therefore lead to different appropriate plans in different patients.

Preoperative imaging and multidisciplinary discussion are important when disease extent is uncertain, there are multiple tumour foci or neoadjuvant treatment has changed the tumour. If breast conservation cannot achieve acceptable cancer clearance, mastectomy may still be the safer recommendation despite reconstructive possibilities.

Immediate versus delayed-immediate reconstruction

Immediate reconstruction uses one anaesthetic and moves unscarred, non-radiated tissue. It often provides the most direct contour restoration and avoids living temporarily with a defect. Its challenge is that final microscopic margin results are not yet available. If a margin is involved, re-excision through rearranged anatomy can be more complex, and mastectomy may occasionally be required.

Delayed-immediate reconstruction separates tumour removal from reshaping by a short interval. The pathology can be reviewed before tissue is moved, while reconstruction still occurs before radiotherapy and major scar contraction. This approach requires two operations and is not available in every health system. Neither timing is universally superior; the right choice depends on the expected margin uncertainty, team logistics and patient preference.

Margins, pathology and radiotherapy planning

Clear surgical margins remain essential. The specimen should be oriented so that the pathologist can identify the involved surface if cancer approaches an edge. Additional cavity shaves may be taken according to local protocol. Reconstructive tissue must not be moved until the breast team is satisfied that required specimens and orientation are complete.

After reshaping, the original tumour bed may no longer lie directly beneath the skin incision. Clips placed around the cavity help the radiation oncologist identify the target for a boost and help future clinicians understand the new anatomy. The operation note should document tumour location, tissue movements, flap type and clip placement.

Oncoplastic surgery generally remains compatible with postoperative radiotherapy, but wound healing must be monitored so that treatment is not unnecessarily delayed. Large reductions, smoking, diabetes and extensive flap surgery may increase wound risk. The oncology and reconstructive teams should agree on the plan before the operation, not after a complication occurs.

What happens on the day of surgery?

Markings are made before anaesthesia, often while standing. The surgeon confirms the cancer side, tumour location, planned incision, reconstructive option and possible alternative. Sentinel lymph-node surgery or other axillary treatment may be performed through the same or a separate incision.

The operation is usually under general anaesthesia. Duration varies considerably: a local tissue rearrangement is shorter than a bilateral reduction or LICAP flap. Removed tissue is sent to pathology. Drains are not always needed after limited displacement but may be used for a perforator-flap donor site or a large internal cavity.

Most patients stay for the day or overnight, depending on the extent of surgery, medical condition and local practice. Before discharge, the team checks the breast and flap, explains dressings and drain care, and gives instructions about arm movement, pain relief and signs that require urgent review.

Recovery after oncoplastic breast surgery

Swelling, bruising, tightness and altered sensation are expected. After displacement or reduction, the breast may initially sit high and feel firm. After LICAP reconstruction, discomfort can occur in both the breast and side-chest donor site, and twisting or reaching may feel tight. The early appearance is not the final shape.

Light walking begins immediately. Arm exercises follow the team's protocol, particularly if lymph-node surgery was also performed. A supportive non-wired bra may be recommended. Many people return to desk-based work within two to four weeks after moderate surgery, but a larger bilateral reduction, perforator flap, complications or physically demanding work can require longer.

Final contour develops over months. Radiotherapy can then change softness, volume and nipple position. Follow-up should assess both cancer treatment and reconstruction. A later small revision or fat-grafting session may refine an edge or residual hollow, but it should not be assumed that further surgery will be necessary.

Risks and possible complications

All breast surgery carries risks of bleeding, infection, delayed healing, seroma, wound separation, altered sensation, pain, poor scarring, asymmetry and the need for another operation. Skin or nipple blood supply can be compromised after extensive displacement or reduction. Fat necrosis may produce a firm area that sometimes needs imaging or biopsy.

Flap-specific problems include partial fat or skin loss, venous congestion, donor-site fluid, contour irregularity, a visible skin paddle and rare complete flap failure. A LICAP flap preserves major muscle, but the lateral scar can widen or remain sensitive. A bulky flap may require later contouring, while inadequate volume can leave residual flattening.

Cancer-specific risks include an involved margin requiring re-excision or mastectomy, difficulty locating the original cavity after rearrangement and delay to radiotherapy if healing is slow. These risks are reduced by coordinated planning, careful documentation and appropriate patient selection, but they cannot be eliminated.

Oncological safety and available evidence

Modern systematic reviews and large pooled analyses generally report that appropriately selected oncoplastic breast-conserving surgery has oncological outcomes comparable with standard breast-conserving surgery. Some analyses report lower re-excision or positive-margin rates, probably because a larger segment can be removed while preserving shape. These results are reassuring but do not mean that wider surgery is automatically safer for every tumour.

Evidence for chest-wall perforator flaps includes prospective and retrospective cohorts with high patient satisfaction and acceptable surgical, cosmetic and survival outcomes. The data are less mature than for standard lumpectomy and include different flap types and patient groups. LICAP should therefore be presented as an established option in experienced teams, not as a guarantee of avoiding mastectomy, re-excision or later asymmetry.

Individual cancer biology, imaging extent, response to systemic therapy, margin results and radiotherapy remain decisive. Population evidence informs the discussion; the multidisciplinary breast team determines whether breast conservation is safe in a particular case.

Who may not be a suitable candidate?

Immediate oncoplastic surgery may be inappropriate when clear margins are unlikely, disease is too extensive for safe conservation, the skin or nipple is involved, or radiotherapy cannot be delivered when it is required. Severe medical illness, active smoking, uncontrolled diabetes, poor donor tissue or previous scars that threaten blood supply may make a complex technique unsafe.

A patient may also reasonably choose a standard lumpectomy, mastectomy with or without reconstruction, or delayed correction. The right operation balances cancer safety, likely breast shape, total treatment burden, scars and personal priorities. A reconstructive possibility should expand informed choice, not pressure someone toward a longer operation.

Questions to ask your breast team

• How large is the expected resection compared with my breast volume?

• What deformity is likely after a standard lumpectomy in this tumour location?

• Would volume displacement or volume replacement be more reliable for me?

• Why is a LICAP flap appropriate, and where will the donor scar sit?

• What alternative will be used if the final cavity differs from the plan?

• How will the specimen be oriented and the tumour bed marked?

• What happens if a margin is involved?

• Could reconstruction delay chemotherapy or radiotherapy if healing is slow?

• Would the other breast need surgery now or later for symmetry?

• How many nights, drains and weeks away from work should I expect?

Frequently asked questions

Is oncoplastic surgery the same as cosmetic breast surgery?

No. It uses plastic-surgery principles, but cancer removal and accurate pathology come first. The aim is to prevent or repair a lumpectomy deformity while preserving oncological safety, not to promise a cosmetic result.

Can oncoplastic surgery help me avoid a mastectomy?

Sometimes. It may allow a larger segment to be removed while maintaining an acceptable breast shape. Mastectomy is still recommended when disease extent, margins, skin involvement or other oncological factors make conservation unsafe.

What is a LICAP flap?

A LICAP flap transfers skin and fat from the side of the chest into a lateral breast defect while keeping the tissue attached to perforating blood vessels. It preserves the major underlying muscles and is commonly used for immediate partial breast reconstruction.

Will the LICAP scar be hidden by my bra?

It can often be positioned along the lateral bra line, but anatomy, flap size and defect location determine the final scar. Your surgeon should show the planned line while you are standing and explain whether any flap skin will remain visible.

What if the pathology margin is positive?

The team reviews which margin is involved and whether further local excision is technically and oncologically appropriate. Because tissue has been rearranged, re-excision needs the original operative map. Some patients require another reshaping procedure or mastectomy.

Can I still receive radiotherapy?

Yes. Oncoplastic breast conservation is normally planned with postoperative radiotherapy in mind. Tumour-bed clips and detailed documentation help treatment planning. Significant wound problems can delay treatment, so healing risk is discussed before surgery.

Will both breasts be operated on?

Not always. A matching reduction or lift may improve symmetry after a large oncoplastic reduction. LICAP reconstruction often treats only the cancer side. Contralateral surgery can be immediate or delayed until radiotherapy-related changes settle.

How long does a LICAP flap take to heal?

Early wounds usually heal over the first weeks, but swelling, tightness and scar sensitivity can continue longer. Many patients resume light daily activity gradually, while heavy lifting and strenuous exercise wait for clearance from the surgical team.

Will mammograms still be possible?

Yes. The conserved breast continues to receive surveillance imaging according to the oncology plan. Tissue rearrangement, clips, scars and fat necrosis can change the appearance, so radiologists should know the operation type and date.

Evidence and further reading

This guide expands on Dr. Foumani's article Oncoplastic Breast Surgery: Combining Cancer Removal with Cosmetic Results. Further background is available from the US National Cancer Institute's overview of oncoplastic breast-conserving surgery, a 2024 meta-analysis comparing oncoplastic with conventional breast-conserving surgery, and clinical outcome research on chest-wall perforator flaps including LICAP.

Educational content based on the work and book Breast Reconstruction Explained by Dr. Mahyar Foumani, plastic and reconstructive surgeon specialising in breast reconstruction. Content updated 15 July 2026. This information supports, but does not replace, multidisciplinary assessment and personalised advice from your breast-cancer and reconstructive team.